Endocannabinoid System May Play Role in Treating Symptoms of Schizophrenia, According to New Study

A new study published in the journal Progress in Neuro-Psychopharmacology & Biological Psychiatry has found that our body’s endocannabinoid system may provideendo a novel target for treatment of schizophrenia symptoms.

“Accumulating evidence suggests involvement of the endocannabinoid system in the pathophysiology of schizophrenia, which signifies a potential application for this system in the treatment of this disorder”, claims the study’s abstract. “Here we review human studies that investigated acute effects of cannabis or ∆9-tetrahydrocannabinol (THC) on brain functions that are implicated in schizophrenia.”

Read moreEndocannabinoid System May Play Role in Treating Symptoms of Schizophrenia, According to New Study